Related Experiment Video
Updated: Sep 20, 2025

17:28
Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation
Published on: June 17, 2015
12.7K
Reproductive and developmental toxicity risk assessment for 4-methylimidazole.
1Scialli Consulting LLC, 2737 Devonshire Pl NW #120, Washington DC, 20008, USA.
Regulatory Toxicology and Pharmacology : RTP
|May 24, 2025
Summary
4-Methylimidazole (4-MEI), found in caramel color, showed reproductive and developmental toxicity in rats at high doses. However, U.S. human dietary exposure levels are unlikely to pose reproductive or developmental risks.
Area of Science:
- Toxicology
- Food Safety
- Risk Assessment
Background:
- 4-Methylimidazole (4-MEI) is a common compound in caramel coloring and a byproduct of food processing.
- Concerns exist regarding potential reproductive and developmental effects of 4-MEI exposure.
Purpose of the Study:
- To assess the reproductive and developmental risks associated with 4-MEI in the human diet.
- To evaluate the safety of 4-MEI based on U.S. dietary exposure data.
Main Methods:
- Utilized data from the National Toxicology Program's Reproductive Assessment by Continuous Breeding study.
- Employed U.S. Food and Drug Administration's 90th percentile dietary exposure data for risk assessment.
- Applied benchmark dose modeling and traditional NOAEL/LOAEL methods to determine margins of exposure (MOE).
Main Results:
- National Toxicology Program identified reproductive and developmental toxicity in rats at high 4-MEI exposure levels.
- The lowest Margin of Exposure (MOE) calculated was 1489 using benchmark dose modeling.
- The MOE at the 90th percentile human consumption level was 735.
- MOEs of 100 or greater are generally considered to be of low concern.
Conclusions:
- Current human dietary exposure to 4-MEI in the United States is not anticipated to pose a risk to reproduction.
- The study suggests that 4-MEI in the diet does not confer developmental risks to the U.S. population.
- Margins of exposure indicate a low level of concern for reproductive and developmental effects from dietary 4-MEI.
Related Concept Videos
Mutagenicity and Carcinogenicity
1.4K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.4K
Teratogenicity
2.8K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.8K

